Valliappan Kannappan
Dr. Valliappan Kannappan, M. Pharm., Ph.D., is a distinguished pharmaceutical scientist and
educator with over four decades of pioneering contributions to chiral chemistry, HPLC method
development, and stereochemical drug analysis. As the visionary founder of Chiralpedia,
he has established a comprehensive digital platform dedicated to advancing chiral science and
its applications in pharmaceuticals, biotechnology, and materials research.
Dr. Valliappan's illustrious career includes:
As Principal Investigator/Coordinator, Dr. Valliappan has successfully mobilized and executed major
research projects worth ₹178 lakhs (≈$2.1M):
- UGC Major Research Project (2014-17): "Chiral HPLC Methods for the Analysis of Selected Drugs
in Pharmaceutical Formulation and Biological Matrices" (₹8.0 lakhs, Completed)
- UGC-DRS Phase II (2015-20): Departmental Research Support in Chiral & Nanotechnology (₹120.5
lakhs, Coordinator, Completed)
- UGC-DRS Phase I (2009-14): Departmental Research Support in Novel Drug Delivery Systems and
Chiral Separation & Analysis (₹41 lakhs, Deputy Coordinator, Completed)
- AICTE R&D Project(2002-05): "Bioequivalence Studies on Chiral Drugs Employing Chiral HPLC
Analysis" (₹6.5 lakhs, Completed)
Core Research Domains
- Chiral HPLC method development for pharmaceutical & biological matrices
- Enantiopurity assessment of chiral switches and pharmaceuticals
- Chemometric optimization of chromatographic separations
- Stereochemical aspects of drug action and disposition
- Analytical method validation and quality control
- Application of artificial intelligence in pharmaceutical analysis
Editorial & Peer Review Contributions
A respected voice in analytical chemistry, Dr. Valliappan serves as a reviewer for leading international
journals, ensuring rigorous scientific standards in:
- Analytical and Bioanalytical Chemistry (Springer)
- Journal of Pharmaceutical and Biomedical Analysis (Elsevier)
- Journal of Separation Science (Wiley)
- Chromatographia (Springer)
- Journal of Chromatographic Science (Oxford)
- Journal of Pharmacy and Pharmaceutical Sciences
- Future Drug Discovery (Taylor & Fran)
- Indian Journal of Pharmaceutical Education
- Indian Drugs
His editorial roles include membership on the boards of Indian Drugs and
the Journal of Phyto-pharmacotherapy and Natural Products.
Global Impact & Knowledge Dissemination
With 80+ publications, 30+
conference presentations, and supervision of 11 Ph.D. theses, Dr. Valliappan has shaped the field of chiral science. His contributions include:
- 86+ invited lectures and 10+
webinars worldwide on chiral separations and drug development
- 21 workshops/seminars organized, including UGC-sponsored programs on chiral
synthesis and analysis
- 15+ popular science articles demystifying chirality for broader audiences
- Wikipedia contributions with 5 key articles:
Vision for Chiralpedia
Chiralpedia embodies Dr. Valliappan's commitment to democratizing chiral knowledge. The
platform integrates his research insights, educational tools, and industry collaborations to:
- Simplify complex stereochemical concepts for students and researchers
- Showcase cutting-edge applications in drug design and quality control
- Foster interdisciplinary dialogue through curated resources and forums
Connect with the Founder:
"In the mirror-world of chirality, small differences create monumental impacts. At Chiralpedia, we
illuminate these nuances to drive innovation in medicine and beyond."
— Dr. Valliappan Kannappan